Dear colleagues,
It is with great pleasure that we announce the recipients of the 2024 Best Publications in Cancer Research Awards.
Our gratitude goes to the Commission and all members for their invaluable contributions to this year’s competition. We are excited to welcome new applications in January 2025.
Best regards,
Board of Directors of SDIR
Introducing the winners of the 2024 SDIR Awards for Best Publications in Cancer Research:
Dear SDIR members,,
We are pleased to announce the results of the Serbian Association for Cancer Research’ competition for the best scientific publication in cancer research. The commission, consisting of:
1. Ph.D. Ljubica Harhaji-Trajković, President
2. Prof. Ph.D. Katarina Zeljić, Member
3. Ph.D. Sandra Arandjelovic, Member
4. Ph.D. Nina Petrović, Member
5. Ph.D. Aleksandar Stojsavljević, Member
convened on March 26, 2024, to reach a decision in accordance with the established guidelines, which was subsequently ratified by the SDIR Executive Committee during its session on March 28-29, 2024.
1. No publications were submitted in the SDIR senior member category.
2. In the junior member category, two awards were presented to colleagues with the highest scores..
Marija Ostojić, Institute of Oncology and Radiology of Serbia, for the original work:
Ostojić M, Jevrić M, Mitrović-Ajtić O, Živić K, Tanić M, Čavić M, Srdić-Rajić T, Grahovac J. Nischarin expression may have differing roles in male and female melanoma patients. Journal of Molecular Medicine 2023;101(8):1001-14. [IF=5,606; M21]
Ph.D. Sofija Jovanović-Stojanov, Institute for Biological Research “Siniša Stanković”, Institute of National Importance for the Republic of Serbia, University of Belgrade, for original work:
Jovanović Stojanov S, Ntungwe EN, Dinić J, Podolski-Renić A, Pajović M, Rijo P, Pešić M. Coleon U, Isolated from Plectranthus mutabilis Codd., Decreases P-Glycoprotein Activity Due to Mitochondrial Inhibition. Pharmaceutics 2023;15(7):1942. [IF=6,525; M21].
All participants have been informed of the competition results via the email address used for their submissions. Candidates may appeal the decision by submitting a letter and/or supporting documentation within 7 days from the date of this announcement(April 9, 2024), after which the decision is considered final. In the event that appeals are filed, the Commission and the SDIR Executive Committee consider the appeals within 7 days after the appeals period has ended and will issue a final ruling.
Best regards,
SDIR Executive Committee